Shares of Vor Biopharma Inc. (NYSE:VOR – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the seven brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price […]